RARE: Ultragenyx Pharmaceutical Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4,104.41
Enterprise Value ($M) 4,807.35
Book Value ($M) 353.83
Book Value / Share 3.83
Price / Book 11.60
NCAV ($M) -424.04
NCAV / Share -4.60
Price / NCAV -9.68

Profitability (mra)
Return on Invested Capital (ROIC) -0.45
Return on Assets (ROA) -0.38
Return on Equity (ROE) -17.95

Liquidity (mrq)
Quick Ratio 2.24
Current Ratio 2.37

Balance Sheet (mrq) ($M)
Current Assets 817.12
Assets 1,503.46
Liabilities 1,241.16
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 560.23
Operating Income -535.97
Net Income -569.18
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -414.19
Cash from Investing -17.77
Cash from Financing 399.24

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-12 13G/A Sands Capital Management, Llc
02-10 13G/A Wellington Management Group Llp
11-14 13G/A Rtw Investments, Lp 2.10 -71.42
2024-02-14 13G/A Price T Rowe Associates Inc /md/ 4.20 -15.69
2024-02-13 13G/A Vanguard Group Inc 10.56 19.86
2024-01-29 13G/A BlackRock, Inc. 6.40 20.80

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 124,773 474,567 26.29
2025-02-20 126,213 487,225 25.90
2025-02-19 116,129 604,414 19.21
2025-02-18 132,621 644,595 20.57

(click for more detail)

Similar Companies
QDEL – QuidelOrtho Corporation QNCX – Quince Therapeutics, Inc.
QURE – uniQure N.V. RDUS – Radius Recycling, Inc.
REGN – Regeneron Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io